Cargando…
The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us?
Autor principal: | Coleman, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767661/ https://www.ncbi.nlm.nih.gov/pubmed/33300315 http://dx.doi.org/10.3802/jgo.2021.32.e20 |
Ejemplares similares
-
What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations
por: Bossi, Paolo, et al.
Publicado: (2021) -
Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013) -
Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review
por: Conte, Carmine, et al.
Publicado: (2021) -
Testicular involvement in pediatric acute lymphocytic leukemia: what to do about it?
por: de Jesus, Lisieux Eyer, et al.
Publicado: (2022) -
DNA methylation studies using twins: what are they telling us?
por: Bell, Jordana T, et al.
Publicado: (2012)